These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 25424941)
21. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model. Yang MC; Tan EC; Su JJ Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648 [TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of rotavirus vaccination in Argentina. Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152 [TBL] [Abstract][Full Text] [Related]
23. Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach. Hayajneh WA; Daniels VJ; James CK; Kanıbir MN; Pilsbury M; Marks M; Goveia MG; Elbasha EH; Dasbach E; Acosta CJ BMC Infect Dis; 2018 Mar; 18(1):119. PubMed ID: 29514609 [TBL] [Abstract][Full Text] [Related]
24. Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada. Ramsay LC; Anyiwe K; Li M; Macdonald L; Coyte PC; Sander B Vaccine; 2019 Mar; 37(11):1467-1475. PubMed ID: 30770225 [TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children. Hankin-Wei A; Rein DB; Hernandez-Romieu A; Kennedy MJ; Bulkow L; Rosenberg E; Trigg M; Nelson NP Vaccine; 2016 Jul; 34(35):4243-4249. PubMed ID: 27317459 [TBL] [Abstract][Full Text] [Related]
26. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China. Zhuang GH; Pan XJ; Wang XL Vaccine; 2008 Aug; 26(35):4608-16. PubMed ID: 18597903 [TBL] [Abstract][Full Text] [Related]
27. Economic analysis of the single-dose immunization strategy against hepatitis A in Argentina. Vizzotti C; Pippo T; Urueña A; Altuna J; Palópoli G; Hernández ML; Artola MF; Fernández H; Orellano P; Cañero-Velasco MC; Ciocca M; Ramonet M; Diosque M Vaccine; 2015 May; 33 Suppl 1():A227-32. PubMed ID: 25919166 [TBL] [Abstract][Full Text] [Related]
28. Cost-utility analysis of hepatitis A prevention among health-care workers in Israel. Chodick G; Lerman Y; Wood F; Aloni H; Peled T; Ashkenazi S J Occup Environ Med; 2002 Feb; 44(2):109-15. PubMed ID: 11851212 [TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness and budget impact analyses of dengue vaccination in Indonesia. Suwantika AA; Supadmi W; Ali M; Abdulah R PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009664. PubMed ID: 34383764 [TBL] [Abstract][Full Text] [Related]
30. Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children. Wong C; Jiang M; You JH PLoS One; 2016; 11(12):e0169030. PubMed ID: 28006012 [TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of HPV vaccination in Belize. Walwyn L; Janusz CB; Clark AD; Prieto E; Waight E; Largaespada N Vaccine; 2015 May; 33 Suppl 1():A174-81. PubMed ID: 25919158 [TBL] [Abstract][Full Text] [Related]
32. Hepatitis A: the costs and benefits of the disease prevention by vaccine, Paraná, Brazil. Zahdi MR; Maluf I; Maluf EM Braz J Infect Dis; 2009 Aug; 13(4):257-61. PubMed ID: 20231986 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda. Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ; Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149 [TBL] [Abstract][Full Text] [Related]
34. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands). Postma MJ; Bos JM; Beutels P; Schilthuis H; van den Hoek JA Vaccine; 2004 May; 22(15-16):1862-7. PubMed ID: 15121296 [TBL] [Abstract][Full Text] [Related]
35. Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States. de Boer PT; Crépey P; Pitman RJ; Macabeo B; Chit A; Postma MJ Value Health; 2016 Dec; 19(8):964-975. PubMed ID: 27987647 [TBL] [Abstract][Full Text] [Related]
36. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates. Jacobs RJ; Rosenthal P; Meyerhoff AS Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653 [TBL] [Abstract][Full Text] [Related]
37. Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools. Navas E; Salleras L; Gisbert R; Dominguez A; Bruguera M; Rodríguez G; Galí N; Prat A Vaccine; 2005 Mar; 23(17-18):2185-9. PubMed ID: 15755592 [TBL] [Abstract][Full Text] [Related]
38. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines. Rozenbaum MH; Sanders EA; van Hoek AJ; Jansen AG; van der Ende A; van den Dobbelsteen G; Rodenburg GD; Hak E; Postma MJ BMJ; 2010 Jun; 340():c2509. PubMed ID: 20519267 [TBL] [Abstract][Full Text] [Related]
39. The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis. Yin J; Ji Z; Liang P; Wu Q; Cui F; Wang F; Liang X; Zhuang G Vaccine; 2015 Jul; 33(31):3731-8. PubMed ID: 26057138 [TBL] [Abstract][Full Text] [Related]
40. Cost-effective analysis of hepatitis A vaccination in Kerala state, India. Gurav YK; Bagepally BS; Chitpim N; Sobhonslidsuk A; Gupte MD; Chaikledkaew U; Thakkinstian A; Thavorncharoensap M PLoS One; 2024; 19(6):e0306293. PubMed ID: 38935781 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]